Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 251

The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.

Multifactorial Mechanism of Sarcopenia and Sarcopenic Obesity. Role of Physical Exercise, Microbiota and Myokines

Open access
Bilski, Jan, Pierzchalski, Piotr, Szczepanik, Marian, Bonior, Joanna, Zoladz, Jerzy·2022·Cells

Abstract

Obesity and ageing place a tremendous strain on the global healthcare system. Age-related sarcopenia is characterized by decreased muscular strength, decreased muscle quantity, quality, and decreased functional performance. Sarcopenic obesity (SO) is a condition that combines sarcopenia and obesity and has a substantial influence on the older adults’ health. Because of the complicated pathophysiology, there are disagreements and challenges in identifying and diagnosing SO. Recently, it has become clear that dysbiosis may play a role in the onset and progression of sarcopenia and SO. Skeletal muscle secretes myokines during contraction, which play an important role in controlling muscle growth, function, and metabolic balance. Myokine dysfunction can cause and aggravate obesity, sarcopenia, and SO. The only ways to prevent and slow the progression of sarcopenia, particularly sarcopenic obesity, are physical activity and correct nutritional support. While exercise cannot completely prevent sarcopenia and age-related loss in muscular function, it can certainly delay development and slow down the rate of sarcopenia. The purpose of this review was to discuss potential pathways to muscle deterioration in obese individuals. We also want to present the current understanding of the role of various factors, including microbiota and myokines, in the process of sarcopenia and SO.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells11010160

Cites

142 of 142 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 142 references

Research works printed but not linked: 294

  1. Zoladz, J.A. (2019). Human body composition and muscle mass. Muscle and Exercise Physiology, Academic Press.
  2. Lee, 2001, Skeletal muscle mass and aging: Regional and whole-body measurement methods, Can. J. Appl. Physiol., 26, 102, 10.1139/h01-008 · DOI
  3. Zoladz, J.A. (2019). Human ageing: Impact on muscle force and power. Muscle and Exercise Physiology, Academic Press.
  4. Sayer, 2019, Sarcopenia, Lancet, 393, 2636, 10.1016/S0140-6736(19)31138-9 · DOI · Paper page
  5. Mitchell, 2012, Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review, Front. Physiol., 3, 260, 10.3389/fphys.2012.00260 · DOI · Paper page
  6. Lauretani, 2003, Age-associated changes in skeletal muscles and their effect on mobility: An operational diagnosis of sarcopenia, J. Appl. Physiol., 95, 1851, 10.1152/japplphysiol.00246.2003 · DOI · Paper page
  7. Tournadre, 2019, Sarcopenia, Jt. Bone Spine, 86, 309, 10.1016/j.jbspin.2018.08.001 · DOI · Paper page
  8. Mesinovic, 2019, Sarcopenia and type 2 diabetes mellitus: A bidirectional relationship, Diabetes Metab. Syndr. Obes., 12, 1057, 10.2147/DMSO.S186600 · DOI · Paper page
  9. Poggiogalle, 2020, Sarcopenic obesity and insulin resistance: Application of novel body composition models, Nutrition, 75–76, 110765, 10.1016/j.nut.2020.110765 · DOI
  10. Kang, D.O., Park, S.Y., Choi, B.G., Na, J.O., Choi, C.U., Kim, E.J., Rha, S.W., Park, C.G., Hong, S.J., and Seo, H.S. (2019). Prognostic Impact of Low Skeletal Muscle Mass on Major Adverse Cardiovascular Events in Coronary Artery Disease: A Propensity Score-Matched Analysis of a Single Center All-Comer Cohort. J. Clin. Med., 8. · DOI
  11. Pacifico, 2020, Prevalence of sarcopenia as a comorbid disease: A systematic review and meta-analysis, Exp. Gerontol., 131, 110801, 10.1016/j.exger.2019.110801 · DOI · Paper page
  12. Kelly, T.L., Wilson, K.E., and Heymsfield, S.B. (2009). Dual energy X-Ray absorptiometry body composition reference values from NHANES. PLoS ONE, 4. · DOI · Paper page
  13. Sieber, 2019, Malnutrition and sarcopenia, Aging Clin. Exp. Res., 31, 793, 10.1007/s40520-019-01170-1 · DOI · Paper page
  14. Landi, 2017, Anorexia of Aging: Assessment and Management, Clin. Geriatr. Med., 33, 315, 10.1016/j.cger.2017.02.004 · DOI
  15. Gros, 2005, A common somitic origin for embryonic muscle progenitors and satellite cells, Nature, 435, 954, 10.1038/nature03572 · DOI · Paper page
  16. Gruberg, 2002, The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: The obesity paradox?, J. Am. Coll. Cardiol., 39, 578, 10.1016/S0735-1097(01)01802-2 · DOI · Paper page
  17. Bosello, 2021, Obesity paradox and aging, Eat Weight Disord., 26, 27, 10.1007/s40519-019-00815-4 · DOI · Paper page
  18. Bahat, 2021, Associations of sarcopenic obesity versus sarcopenia alone with functionality, Clin. Nutr., 40, 2851, 10.1016/j.clnu.2021.04.002 · DOI
  19. Alalwan, T.A. (2020). Phenotypes of Sarcopenic Obesity: Exploring the Effects on Peri-Muscular Fat, the Obesity Paradox, Hormone-Related Responses and the Clinical Implications. Geriatrics, 5. · DOI
  20. Manolopoulos, 2010, Gluteofemoral body fat as a determinant of metabolic health, Int. J. Obes., 34, 949, 10.1038/ijo.2009.286 · DOI · Paper page
  21. Larsson, 2019, Sarcopenia: Aging-Related Loss of Muscle Mass and Function, Physiol. Rev., 99, 427, 10.1152/physrev.00061.2017 · DOI · Paper page
  22. Gustafsson, 2021, Sarcopenia: What Is the Origin of This Aging-Induced Disorder?, Front. Genet., 12, 688526, 10.3389/fgene.2021.688526 · DOI
  23. Wickramasinghe, 2020, From lifespan to healthspan: The role of nutrition in healthy ageing, J. Nutr. Sci., 9, e33, 10.1017/jns.2020.26 · DOI
  24. Murphy, 2018, Nutrition and physical activity countermeasures for sarcopenia: Time to get personal?, Nutr. Bull., 43, 374, 10.1111/nbu.12351 · DOI
  25. Kitada, 2021, Autophagy in metabolic disease and ageing, Nat. Rev. Endocrinol., 17, 647, 10.1038/s41574-021-00551-9 · DOI · Paper page
  26. Wilkinson, 2018, The age-related loss of skeletal muscle mass and function: Measurement and physiology of muscle fibre atrophy and muscle fibre loss in humans, Ageing Res. Rev., 47, 123, 10.1016/j.arr.2018.07.005 · DOI · Paper page
  27. Sakuma, K. (2021). The role of the neuromuscular junction in sarcopenia. Sarcopenia, Elsevier.
  28. McCormick, 2018, Age-related changes in skeletal muscle: Changes to life-style as a therapy, Biogerontology, 19, 519, 10.1007/s10522-018-9775-3 · DOI · Paper page
  29. Yamakawa, H., Kusumoto, D., Hashimoto, H., and Yuasa, S. (2020). Stem Cell Aging in Skeletal Muscle Regeneration and Disease. Int. J. Mol. Sci., 21. · DOI · Paper page
  30. Carosio, 2011, Impact of ageing on muscle cell regeneration, Ageing Res. Rev., 10, 35, 10.1016/j.arr.2009.08.001 · DOI
  31. Yoshida, T., and Delafontaine, P. (2020). Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy. Cells, 9. · DOI · Paper page
  32. Sakuma, 2017, Molecular mechanism of sarcopenia and cachexia: Recent research advances, Pflug. Arch., 469, 573, 10.1007/s00424-016-1933-3 · DOI
  33. Metcalf, 1963, The Autonomous Behaviour of Normal Thymus Grafts, Aust. J. Exp. Biol. Med. Sci., 41, SUPPL437, 10.1038/icb.1963.64 · doi:10.1038/icb.1963.64
  34. Metcalf, 1964, Restricted Growth Capacity of Multiple Spleen Grafts, Transplantation, 2, 387, 10.1097/00007890-196405000-00008 · DOI
  35. Huang, 2005, The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP, Cell, 122, 421, 10.1016/j.cell.2005.06.007 · DOI · Paper page
  36. Callus, 2006, Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation, FEBS J., 273, 4264, 10.1111/j.1742-4658.2006.05427.x · DOI · Paper page
  37. Pobbati, 2012, Structural and functional similarity between the Vgll1-TEAD and the YAP-TEAD complexes, Structure, 20, 1135, 10.1016/j.str.2012.04.004 · DOI · Paper page
  38. Hong, 2012, The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway, Semin. Cell. Dev. Biol., 23, 785, 10.1016/j.semcdb.2012.05.004 · DOI · Paper page
  39. Hutchison, 1998, Isolation of TAO1, a protein kinase that activates MEKs in stress-activated protein kinase cascades, J. Biol. Chem., 273, 28625, 10.1074/jbc.273.44.28625 · DOI
  40. Boggiano, 2011, Tao-1 phosphorylates Hippo/MST kinases to regulate the Hippo-Salvador-Warts tumor suppressor pathway, Dev. Cell., 21, 888, 10.1016/j.devcel.2011.08.028 · DOI · Paper page
  41. Chen, 1999, Isolation of the protein kinase TAO2 and identification of its mitogen-activated protein kinase/extracellular signal-regulated kinase kinase binding domain, J. Biol. Chem., 274, 28803, 10.1074/jbc.274.40.28803 · DOI
  42. Lei, 2008, TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway, Mol. Cell. Biol., 28, 2426, 10.1128/MCB.01874-07 · DOI · Paper page
  43. Praskova, 2008, MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation, Curr. Biol., 18, 311, 10.1016/j.cub.2008.02.006 · DOI · Paper page
  44. Sudol, 1994, Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product, Oncogene, 9, 2145
  45. Zhou, 2009, Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene, Cancer Cell, 16, 425, 10.1016/j.ccr.2009.09.026 · DOI · Paper page
  46. Porstmann, 2008, SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth, Cell Metab., 8, 224, 10.1016/j.cmet.2008.07.007 · DOI · Paper page
  47. Richter, 2005, Regulation of cap-dependent translation by eIF4E inhibitory proteins, Nature, 433, 477, 10.1038/nature03205 · DOI · Paper page
  48. Sudol, 1995, Characterization of a novel protein-binding module–the WW domain, FEBS Lett., 369, 67, 10.1016/0014-5793(95)00550-S · DOI · Paper page
  49. Carson, 1996, SRF and TEF-1 control of chicken skeletal alpha-actin gene during slow-muscle hypertrophy, Am. J. Physiol., 270, C1624, 10.1152/ajpcell.1996.270.6.C1624 · DOI · Paper page
  50. Judson, R.N., Gray, S.R., Walker, C., Carroll, A.M., Itzstein, C., Lionikas, A., Zammit, P.S., De Bari, C., and Wackerhage, H. (2013). Constitutive expression of Yes-associated protein (Yap) in adult skeletal muscle fibres induces muscle atrophy and myopathy. PLoS ONE, 8. · DOI
  51. Hulmi, 2013, Muscle protein synthesis, mTORC1/MAPK/Hippo signaling, and capillary density are altered by blocking of myostatin and activins, Am. J. Physiol. Endocrinol. Metab., 304, E41, 10.1152/ajpendo.00389.2012 · DOI
  52. Tremblay, 2014, The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation, Cancer Cell, 26, 273, 10.1016/j.ccr.2014.05.029 · DOI · Paper page
  53. Wei, B., Dui, W., Liu, D., Xing, Y., Yuan, Z., and Ji, G. (2013). MST1, a key player, in enhancing fast skeletal muscle atrophy. BMC Biol., 11. · DOI
  54. Sun, 2017, Common and Distinctive Functions of the Hippo Effectors Taz and Yap in Skeletal Muscle Stem Cell Function, Stem Cells, 35, 1958, 10.1002/stem.2652 · DOI
  55. You, 2009, Phosphorylation of cardiac troponin I by mammalian sterile 20-like kinase 1, Biochem. J., 418, 93, 10.1042/BJ20081340 · DOI
  56. Odashima, 2007, Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction, Circ. Res., 100, 1344, 10.1161/01.RES.0000265846.23485.7a · DOI · Paper page
  57. Ray, 2018, Immune senescence, epigenetics and autoimmunity, Clin. Immunol., 196, 59, 10.1016/j.clim.2018.04.002 · DOI · Paper page
  58. Barberi, 2013, Age-dependent alteration in muscle regeneration: The critical role of tissue niche, Biogerontology, 14, 273, 10.1007/s10522-013-9429-4 · DOI
  59. Mitch, 1996, Mechanisms of muscle wasting—the role of the ubiquitin–proteasome pathway, N. Engl. J. Med., 335, 1897, 10.1056/NEJM199612193352507 · DOI · Paper page
  60. Ferrucci, 1999, Serum IL-6 level and the development of disability in older persons, J. Am. Geriatr. Soc., 47, 639, 10.1111/j.1532-5415.1999.tb01583.x · DOI · Paper page
  61. Lang, 2007, Regulation of muscle protein synthesis during sepsis and inflammation, Am. J. Physiol. Endocrinol. Metab., 293, E453, 10.1152/ajpendo.00204.2007 · DOI · Paper page
  62. Frost, 2007, Protein kinase B/Akt: A nexus of growth factor and cytokine signaling in determining muscle mass, J. Appl. Physiol., 103, 378, 10.1152/japplphysiol.00089.2007 · DOI · Paper page
  63. Haran, 2012, Role and potential mechanisms of anabolic resistance in sarcopenia, J. Cachexia Sarcopenia Muscle, 3, 157, 10.1007/s13539-012-0068-4 · DOI · Paper page
  64. Bano, 2017, Inflammation and sarcopenia: A systematic review and meta-analysis, Maturitas, 96, 10, 10.1016/j.maturitas.2016.11.006 · DOI · Paper page
  65. Cleasby, 2016, Insulin resistance and sarcopenia: Mechanistic links between common co-morbidities, J. Endocrinol., 229, R67, 10.1530/JOE-15-0533 · DOI · Paper page
  66. Moore, 2015, Protein ingestion to stimulate myofibrillar protein synthesis requires greater relative protein intakes in healthy older versus younger men, J. Gerontol. A Biol. Sci. Med. Sci., 70, 57, 10.1093/gerona/glu103 · DOI · Paper page
  67. Kumar, 2012, Muscle protein synthetic responses to exercise: Effects of age, volume, and intensity, J. Gerontol. A Biol. Sci. Med. Sci., 67, 1170, 10.1093/gerona/gls141 · DOI
  68. Meex, 2019, Lipotoxicity plays a key role in the development of both insulin resistance and muscle atrophy in patients with type 2 diabetes, Obes. Rev., 20, 1205, 10.1111/obr.12862 · DOI · Paper page
  69. Saini, 2016, Regenerative function of immune system: Modulation of muscle stem cells, Ageing Res. Rev., 27, 67, 10.1016/j.arr.2016.03.006 · DOI
  70. Kuswanto, 2016, Poor Repair of Skeletal Muscle in Aging Mice Reflects a Defect in Local, Interleukin-33-Dependent Accumulation of Regulatory T Cells, Immunity, 44, 355, 10.1016/j.immuni.2016.01.009 · DOI · Paper page
  71. Reidy, 2019, Aging impairs mouse skeletal muscle macrophage polarization and muscle-specific abundance during recovery from disuse, Am. J. Physiol. Endocrinol. Metab., 317, E85, 10.1152/ajpendo.00422.2018 · DOI
  72. Afzali, 2018, Skeletal muscle cells actively shape (auto)immune responses, Autoimmun. Rev., 17, 518, 10.1016/j.autrev.2017.12.005 · DOI
  73. Thevaranjan, 2018, Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction, Cell Host Microbe, 23, 570, 10.1016/j.chom.2018.03.006 · DOI · Paper page
  74. Strzepa, 2018, Antibiotics and autoimmune and allergy diseases: Causative factor or treatment?, Int. Immunopharmacol., 65, 328, 10.1016/j.intimp.2018.10.021 · DOI
  75. Younes, 2018, Women and their microbes: The unexpected friendship, Trends Microbiol., 26, 16, 10.1016/j.tim.2017.07.008 · DOI · Paper page
  76. Hill, 2009, Intestinal bacteria and the regulation of immune cell homeostasis, Annu. Rev. Immunol., 28, 623, 10.1146/annurev-immunol-030409-101330 · DOI · Paper page
  77. Janssen, 2015, The role of the gut microbiota in metabolic health, FASEB J., 29, 3111, 10.1096/fj.14-269514 · DOI · Paper page
  78. Durack, 2019, The gut microbiome: Relationships with disease and opportunities for therapy, J. Exp. Med., 216, 20, 10.1084/jem.20180448 · DOI · Paper page
  79. Picca, 2018, Gut Dysbiosis and Muscle Aging: Searching for Novel Targets against Sarcopenia, Mediat. Inflamm., 2018, 7026198, 10.1155/2018/7026198 · DOI · Paper page
  80. Conway, 2021, Ageing of the gut microbiome: Potential influences on immune senescence and inflammageing, Ageing Res. Rev., 68, 101323, 10.1016/j.arr.2021.101323 · DOI · Paper page
  81. Fielding, 2019, Muscle strength is increased in mice that are colonized with microbiota from high-functioning older adults, Exp. Gerontol., 127, 110722, 10.1016/j.exger.2019.110722 · DOI · Paper page
  82. Zhao, 2021, A Narrative Review of Gut-Muscle Axis and Sarcopenia: The Potential Role of Gut Microbiota, Int. J. Gen. Med., 14, 1263, 10.2147/IJGM.S301141 · DOI
  83. Lee, M.-C., Hsu, Y.-J., Ho, H.-H., Hsieh, S.-H., Kuo, Y.-W., Sung, H.-C., and Huang, C.-C. (2020). Lactobacillus salivarius Subspecies salicinius SA-03 is a new probiotic capable of enhancing exercise performance and decreasing fatigue. Microorganisms, 8. · DOI
  84. Lee, M.C., Hsu, Y.J., Chuang, H.L., Hsieh, P.S., Ho, H.H., Chen, W.L., Chiu, Y.S., and Huang, C.C. (2019). In Vivo Ergogenic Properties of the Bifidobacterium longum OLP-01 Isolated from a Weightlifting Gold Medalist. Nutrients, 11. · DOI
  85. Folwarski, 2020, The use of Lactobacillus plantarum 299v (DSM 9843) in cancer patients receiving home enteral nutrition - study protocol for a randomized, double-blind, and placebo-controlled trial, Nutr. J., 19, 98, 10.1186/s12937-020-00598-w · DOI
  86. Bindels, L.B., Beck, R., Schakman, O., Martin, J.C., De Backer, F., Sohet, F.M., Dewulf, E.M., Pachikian, B.D., Neyrinck, A.M., and Thissen, J.P. (2012). Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model. PLoS ONE, 7. · DOI · Paper page
  87. Liao, 2020, Exploring the Preventive Effect and Mechanism of Senile Sarcopenia Based on "Gut-Muscle Axis", Front. Bioeng. Biotechnol., 8, 590869, 10.3389/fbioe.2020.590869 · DOI
  88. Akdis, 2021, Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?, Nat. Rev. Immunol., 21, 739, 10.1038/s41577-021-00538-7 · DOI · Paper page
  89. Edeas, 2016, Microbiota-mitochondria inter-talk: Consequence for microbiota-host interaction, Pathog. Dis., 74, ftv096, 10.1093/femspd/ftv096 · DOI · Paper page
  90. Mottawea, 2016, Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn’s disease, Nat. Commun., 7, 13419, 10.1038/ncomms13419 · DOI · Paper page
  91. Lipina, 2017, Lipid modulation of skeletal muscle mass and function, J. Cachexia Sarcopenia Muscle, 8, 190, 10.1002/jcsm.12144 · DOI · Paper page
  92. Kwon, K.-S. (2021). Molecular mechanisms of exercise providing therapeutic rationale to counter sarcopenia. Sarcopenia, Elsevier. · DOI
  93. Mincey, 2016, Obesity Epidemiology Worldwide, Gastroenterol. Clin. N. Am., 45, 571, 10.1016/j.gtc.2016.07.012 · DOI · Paper page
  94. Mathis, 2013, Immunological goings-on in visceral adipose tissue, Cell Metab., 17, 851, 10.1016/j.cmet.2013.05.008 · DOI · Paper page
  95. Cypess, 2009, Identification and importance of brown adipose tissue in adult humans, N. Engl. J. Med., 360, 1509, 10.1056/NEJMoa0810780 · DOI · Paper page
  96. Ellulu, 2017, Obesity and inflammation: The linking mechanism and the complications, Arch. Med. Sci., 13, 851, 10.5114/aoms.2016.58928 · DOI · Paper page
  97. Hruby, 2015, The Epidemiology of Obesity: A Big Picture, Pharmacoeconomics, 33, 673, 10.1007/s40273-014-0243-x · DOI · Paper page
  98. Lanthier, 2014, Adipose tissues as endocrine target organs, Best Pract. Res. Clin. Gastroenterol., 28, 545, 10.1016/j.bpg.2014.07.002 · DOI
  99. Wu, 2012, Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human, Cell, 150, 366, 10.1016/j.cell.2012.05.016 · DOI · Paper page
  100. Rosenwald, 2014, The origin and definition of brite versus white and classical brown adipocytes, Adipocyte, 3, 4, 10.4161/adip.26232 · DOI · Paper page
  101. Dempersmier, 2015, Shades of brown: A model for thermogenic fat, Front. Endocrinol., 6, 71, 10.3389/fendo.2015.00071 · DOI
  102. Kredel, 2014, Adipose-tissue and intestinal inflammation - visceral obesity and creeping fat, Front. Immunol., 5, 462, 10.3389/fimmu.2014.00462 · DOI
  103. Tchkonia, 2013, Mechanisms and Metabolic Implications of Regional Differences among Fat Depots, Cell Metab., 17, 644, 10.1016/j.cmet.2013.03.008 · DOI · Paper page
  104. Roman, 2015, Brown adipose tissue and novel therapeutic approaches to treat metabolic disorders, Transl. Res., 165, 464, 10.1016/j.trsl.2014.11.002 · DOI
  105. Nam, 2017, Obesity-Related Digestive Diseases and Their Pathophysiology, Gut Liver, 11, 323, 10.5009/gnl15557 · DOI
  106. Galliano, 2013, Female obesity: Short- and long-term consequences on the offspring, Gynecol. Endocrinol., 29, 626, 10.3109/09513590.2013.777420 · DOI
  107. Brestoff, 2015, Immune regulation of metabolic homeostasis in health and disease, Cell, 161, 146, 10.1016/j.cell.2015.02.022 · DOI · Paper page
  108. Russo, 2018, Properties and functions of adipose tissue macrophages in obesity, Immunology, 155, 407, 10.1111/imm.13002 · DOI · Paper page
  109. Watt, 2021, Yap regulates skeletal muscle fatty acid oxidation and adiposity in metabolic disease, Nat. Commun., 12, 2887, 10.1038/s41467-021-23240-7 · DOI
  110. Sun, 2012, Mechanisms of inflammatory responses in obese adipose tissue, Annu. Rev. Nutr., 32, 261, 10.1146/annurev-nutr-071811-150623 · DOI · Paper page
  111. Jin, 2013, Innate sensors of pathogen and stress: Linking inflammation to obesity, J. Allergy Clin. Immunol., 132, 287, 10.1016/j.jaci.2013.06.022 · DOI · Paper page
  112. Goody, 2019, MicroRNAs in brown and beige fat, Biochim. Biophys. Acta Mol. Cell. Biol. Lipids, 1864, 29, 10.1016/j.bbalip.2018.05.003 · DOI · Paper page
  113. Lee, M.W., Lee, M., and Oh, K.J. (2019). Adipose Tissue-Derived Signatures for Obesity and Type 2 Diabetes: Adipokines, Batokines and MicroRNAs. J. Clin. Med., 8. · DOI · Paper page
  114. Weidinger, 2018, Adipokines and their role in intestinal inflammation, Front. Immunol., 9, 1974, 10.3389/fimmu.2018.01974 · DOI
  115. Bucci, 2013, Circulating levels of adipokines and IGF-1 are associated with skeletal muscle strength of young and old healthy subjects, Biogerontology, 14, 261, 10.1007/s10522-013-9428-5 · DOI
  116. Adams, 2008, Induction of MuRF1 is essential for TNF-α-induced loss of muscle function in mice, J. Mol. Biol., 384, 48, 10.1016/j.jmb.2008.08.087 · DOI
  117. Kelesidis, 2010, Narrative review: The role of leptin in human physiology: Emerging clinical applications, Ann. Intern. Med., 152, 93, 10.7326/0003-4819-152-2-201001190-00008 · DOI · Paper page
  118. Canelles, 2018, The increase in fiber size in male rat gastrocnemius after chronic central leptin infusion is related to activation of insulin signaling, Mol. Cell. Endocrinol., 470, 48, 10.1016/j.mce.2017.09.029 · DOI
  119. Hamrick, 2010, The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice, Biochem. Biophys. Res. Commun., 400, 379, 10.1016/j.bbrc.2010.08.079 · DOI · Paper page
  120. Tazawa, R., Uchida, K., Fujimaki, H., Miyagi, M., Inoue, G., Sekiguchi, H., Murata, K., Takata, K., Kawakubo, A., and Takaso, M. (2019). Elevated leptin levels induce inflammation through IL-6 in skeletal muscle of aged female rats. BMC Musculoskelet. Disord., 20. · DOI
  121. Vella, 2018, Associations of Abdominal Muscle Area and Radiodensity with Adiponectin and Leptin: The Multiethnic Study of Atherosclerosis, Obesity, 26, 1234, 10.1002/oby.22208 · DOI
  122. Lana, 2017, Serum leptin concentration is associated with incident frailty in older adults, Aging Dis., 8, 240, 10.14336/AD.2016.0819 · DOI
  123. Yang, 2021, Examining the Association Between Serum Leptin and Sarcopenic Obesity, J. Inflamm. Res., 14, 3481, 10.2147/JIR.S320445 · DOI
  124. Khoramipour, K., Chamari, K., Hekmatikar, A.A., Ziyaiyan, A., Taherkhani, S., Elguindy, N.M., and Bragazzi, N.L. (2021). Adiponectin: Structure, Physiological Functions, Role in Diseases, and Effects of Nutrition. Nutrients, 13. · DOI · Paper page
  125. Gamberi, 2016, Activation of autophagy by globular adiponectin is required for muscle differentiation, Biochim. Et Biophys. Acta (BBA)-Mol. Cell Res., 1863, 694, 10.1016/j.bbamcr.2016.01.016 · DOI
  126. Fiaschi, T. (2019). Mechanisms of Adiponectin Action, Multidisciplinary Digital Publishing Institute. · DOI
  127. Liu, 2014, Adiponectin action in skeletal muscle, Best Pract. Res. Clin. Endocrinol. Metab., 28, 33, 10.1016/j.beem.2013.08.003 · DOI
  128. Zhou, 2007, Evidence for adipose-muscle cross talk: Opposing regulation of muscle proteolysis by adiponectin and Fatty acids, Endocrinology, 148, 5696, 10.1210/en.2007-0183 · DOI
  129. Baker, 2019, The Adiponectin Paradox in the Elderly: Associations With Body Composition, Physical Functioning, and Mortality, J. Gerontol. A Biol. Sci. Med. Sci., 74, 247, 10.1093/gerona/gly017 · DOI
  130. Rossi, 2019, Influence of skeletal muscle mass and fat mass on the metabolic and inflammatory profile in sarcopenic and non-sarcopenic overfat elderly, Aging Clin. Exp. Res., 31, 629, 10.1007/s40520-018-1029-3 · DOI
  131. Tripathi, 2020, Resistin in metabolism, inflammation, and disease, FEBS J., 287, 3141, 10.1111/febs.15322 · DOI · Paper page
  132. Cushman, 2018, Abdominal muscle density is inversely related to adiposity inflammatory mediators, Med. Sci. Sports Exerc., 50, 1495, 10.1249/MSS.0000000000001570 · DOI
  133. Sheng, 2013, Human resistin inhibits myogenic differentiation and induces insulin resistance in myocytes, Biomed. Res. Int., 2013, 804632, 10.1155/2013/804632 · DOI
  134. Wallace, 2018, Obese subcutaneous adipose tissue impairs human myogenesis, particularly in old skeletal muscle, via resistin-mediated activation of NFkappaB, Sci. Rep., 8, 15360, 10.1038/s41598-018-33840-x · DOI
  135. Waters, 2019, Intermuscular Adipose Tissue: A Brief Review of Etiology, Association With Physical Function and Weight Loss in Older Adults, Ann. Geriatr. Med. Res., 23, 3, 10.4235/agmr.19.0001 · DOI
  136. Konopka, 2018, Relationship between intermuscular adipose tissue infiltration and myostatin before and after aerobic exercise training, Am. J. Physiol. Regul. Integr. Comp. Physiol., 315, R461, 10.1152/ajpregu.00030.2018 · DOI
  137. Gueugneau, 2015, Skeletal muscle lipid content and oxidative activity in relation to muscle fiber type in aging and metabolic syndrome, J. Gerontol. A Biol. Sci. Med. Sci., 70, 566, 10.1093/gerona/glu086 · DOI · Paper page
  138. Mastrocola, R., Collino, M., Nigro, D., Chiazza, F., D’Antona, G., Aragno, M., and Minetto, M.A. (2015). Accumulation of advanced glycation end-products and activation of the SCAP/SREBP Lipogenetic pathway occur in diet-induced obese mouse skeletal muscle. PLoS ONE, 10. · DOI
  139. Biferali, 2019, Fibro-Adipogenic Progenitors Cross-Talk in Skeletal Muscle: The Social Network, Front. Physiol., 10, 1074, 10.3389/fphys.2019.01074 · DOI · Paper page
  140. Collao, 2020, Role of Metabolic Stress and Exercise in Regulating Fibro/Adipogenic Progenitors, Front. Cell Dev. Biol., 8, 9, 10.3389/fcell.2020.00009 · DOI
  141. Li, 2019, The Unique Metabolic Characteristics of Bone Marrow Adipose Tissue, Front. Endocrinol., 10, 69, 10.3389/fendo.2019.00069 · DOI
  142. Krings, 2012, Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes, Bone, 50, 546, 10.1016/j.bone.2011.06.016 · DOI · Paper page
  143. Cawthorn, 2014, Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction, Cell Metab., 20, 368, 10.1016/j.cmet.2014.06.003 · DOI · Paper page
  144. Sulston, 2016, Bone marrow adipose tissue as an endocrine organ: Close to the bone?, Horm. Mol. Biol. Clin. Investig., 28, 21, 10.1515/hmbci-2016-0012 · DOI
  145. Yue, 2016, Leptin Receptor Promotes Adipogenesis and Reduces Osteogenesis by Regulating Mesenchymal Stromal Cells in Adult Bone Marrow, Cell Stem Cell, 18, 782, 10.1016/j.stem.2016.02.015 · DOI · Paper page
  146. Yakabe, 2020, Updated concept of sarcopenia based on muscle-bone relationship, J. Bone Miner. Metab., 38, 7, 10.1007/s00774-019-01048-2 · DOI
  147. Musumeci, G. (2017). Sarcopenia and exercise “The State of the Art”. J. Funct. Morphol. Kinesiol., 2. · DOI
  148. Yoo, 2018, Role of exercise in age-related sarcopenia, J. Exerc. Rehabil., 14, 551, 10.12965/jer.1836268.134 · DOI · Paper page
  149. Wada, 2011, Hippo pathway regulation by cell morphology and stress fibers, Development, 138, 3907, 10.1242/dev.070987 · DOI · Paper page
  150. Aragona, 2013, A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors, Cell, 154, 1047, 10.1016/j.cell.2013.07.042 · DOI · Paper page
  151. Heo, 2017, Aging-induced Sarcopenia and Exercise, Off. J. Korean Acad. Kinesiol., 19, 43, 10.15758/jkak.2017.19.2.43 · doi:10.15758/jkak.2017.19.2.43
  152. Forbes, 2012, Exercise and nutritional interventions for improving aging muscle health, Endocrine, 42, 29, 10.1007/s12020-012-9676-1 · DOI
  153. Erlich, 2016, Function of specialized regulatory proteins and signaling pathways in exercise-induced muscle mitochondrial biogenesis, Integr. Med. Res., 5, 187, 10.1016/j.imr.2016.05.003 · DOI
  154. Ko, 2014, Aerobic exercise affects myostatin expression in aged rat skeletal muscles: A possibility of antiaging effects of aerobic exercise related with pelvic floor muscle and urethral rhabdosphincter, Int. Neurourol. J., 18, 77, 10.5213/inj.2014.18.2.77 · DOI
  155. Bouaziz, 2015, Health benefits of endurance training alone or combined with diet for obese patients over 60: A review, Int. J. Clin. Pract., 69, 1032, 10.1111/ijcp.12648 · DOI
  156. Liberman, 2017, The effects of exercise on muscle strength, body composition, physical functioning and the inflammatory profile of older adults: A systematic review, Curr. Opin. Clin. Nutr. Metab. Care, 20, 30, 10.1097/MCO.0000000000000335 · DOI
  157. Scott, 2015, Exercise with blood flow restriction: An updated evidence-based approach for enhanced muscular development, Sports Med., 45, 313, 10.1007/s40279-014-0288-1 · DOI · Paper page
  158. Hughes, 2017, Blood flow restriction training in clinical musculoskeletal rehabilitation: A systematic review and meta-analysis, Br. J. Sports Med., 51, 1003, 10.1136/bjsports-2016-097071 · DOI · Paper page
  159. Porcari, 2002, Effects of electrical muscle stimulation on body composition, muscle strength, and physical appearance, J. Strength Cond. Res., 16, 165
  160. Musumeci, G. (2017). The use of vibration as physical exercise and therapy. J. Funct. Morphol. Kinesiol., 2. · DOI
  161. Kokkinos, 2012, Physical activity, health benefits, and mortality risk, Int. Sch. Res. Not. Cardiol., 2012, 718789
  162. Li, 2019, Muscle-secreted granulocyte colony-stimulating factor functions as metabolic niche factor ameliorating loss of muscle stem cells in aged mice, EMBO J., 38, e102154, 10.15252/embj.2019102154 · DOI
  163. Scharf, G., and Heineke, J. (2012). Finding Good Biomarkers for Sarcopenia, Springer. · DOI
  164. Han, 2018, The functions of sarcopenia related myokines, Transl. Med. Aging, 2, 38, 10.1016/j.tma.2018.08.001 · DOI
  165. Aryana, 2018, Myokine regulation as marker of sarcopenia in elderly, Mol. Cell. Biomed. Sci., 2, 38, 10.21705/mcbs.v2i2.32 · DOI
  166. Castro, 2017, Insulin-like growth factor i (igf-1) in older adults: A review, MOJ Gerontol. Geriatr., 1, 175
  167. Ahmad, S.S., Ahmad, K., Lee, E.J., Lee, Y.-H., and Choi, I. (2020). Implications of Insulin-Like Growth Factor-1 in Skeletal Muscle and Various Diseases. Cells, 9. · DOI · Paper page
  168. Bando, 1991, Impaired secretion of growth hormone-releasing hormone, growth hormone and IGF-I in elderly men, Acta Endocrinol., 124, 31
  169. Naranjo, 2017, Regenerative Medicine Approaches for Age-Related Muscle Loss and Sarcopenia: A Mini-Review, Gerontology, 63, 580, 10.1159/000479278 · DOI
  170. Yamamoto, 1991, Effects of aging and sex on plasma insulin-like growth factor I (IGF-I) levels in normal adults, Acta Endocrinol., 124, 497
  171. Zhu, H., Xu, Y., Gong, F., Shan, G., Yang, H., Xu, K., Zhang, D., Cheng, X., Zhang, Z., and Chen, S. (2017). Reference ranges for serum insulin-like growth factor I (IGF-I) in healthy Chinese adults. PLoS ONE, 12. · DOI
  172. Haden, 2000, Effects of age on serum dehydroepiandrosterone sulfate, IGF-I, and IL-6 levels in women, Calcif. Tissue Int., 66, 414, 10.1007/s002230010084 · DOI
  173. Moran, 2007, Alterations in IGF-I affect elderly: Role of physical activity, Eur. Rev. Aging Phys. Act., 4, 77, 10.1007/s11556-007-0022-1 · DOI
  174. Carlson, 2019, IGFBP-2 and aging: A 20-year longitudinal study on IGFBP-2, IGF-I, BMI, insulin sensitivity and mortality in an aging population, Eur. J. Endocrinol., 180, 109, 10.1530/EJE-18-0422 · DOI
  175. Ferrari, 2021, IGF-I/IGFBP3/ALS Deficiency in Sarcopenia: Low GHBP Suggests GH Resistance in a Subgroup of Geriatric Patients, J. Clin. Endocrinol. Metab., 106, e1698, 10.1210/clinem/dgaa972 · DOI
  176. Chew, 2019, Serum myostatin and IGF-1 as gender-specific biomarkers of frailty and low muscle mass in community-dwelling older adults, J. Nutr. Health Aging, 23, 979, 10.1007/s12603-019-1255-1 · DOI · Paper page
  177. Tay, 2015, Sex-specific differences in risk factors for sarcopenia amongst community-dwelling older adults, Age, 37, 121, 10.1007/s11357-015-9860-3 · DOI · Paper page
  178. Poggiogalle, E., Lubrano, C., Gnessi, L., Mariani, S., Lenzi, A., and Donini, L.M. (2016). Fatty Liver Index Associates with Relative Sarcopenia and GH/IGF-1 Status in Obese Subjects. PLoS ONE, 11. · DOI
  179. Cassilhas, 2010, Mood, anxiety, and serum IGF-1 in elderly men given 24 weeks of high resistance exercise, Percept. Mot. Ski., 110, 265, 10.2466/pms.110.1.265-276 · DOI
  180. Tsai, 2015, The effects of long-term resistance exercise on the relationship between neurocognitive performance and GH, IGF-1, and homocysteine levels in the elderly, Front. Behav. Neurosci., 9, 23, 10.3389/fnbeh.2015.00023 · DOI · Paper page
  181. Kang, 2020, Effects of aquatic exercise on insulin-like growth factor-1, brain-derived neurotrophic factor, vascular endothelial growth factor, and cognitive function in elderly women, Exp. Gerontol., 132, 110842, 10.1016/j.exger.2020.110842 · DOI
  182. Arazi, H., Babaei, P., Moghimi, M., and Asadi, A. (2021). Acute effects of strength and endurance exercise on serum BDNF and IGF-1 levels in older men. BMC Geriatr., 21. · DOI
  183. Deuschle, 1998, Endurance training and its effect upon the activity of the GH-IGFs system in the elderly, Int. J. Sports Med., 19, 250, 10.1055/s-2007-971913 · DOI
  184. Singh, 1999, Insulin-like growth factor I in skeletal muscle after weight-lifting exercise in frail elders, Am. J. Physiol., 277, E135
  185. Consitt, 2018, The Vicious Cycle of Myostatin Signaling in Sarcopenic Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications for Clinical Trials, J. Frailty Aging, 7, 21
  186. Sharma, 1999, Myostatin, a transforming growth factor-β superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct, J. Cell. Physiol., 180, 1, 10.1002/(SICI)1097-4652(199907)180:1<1::AID-JCP1>3.0.CO;2-V · DOI · Paper page
  187. Goodman, 2013, Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo, Mol. Endocrinol., 27, 1946, 10.1210/me.2013-1194 · DOI
  188. Morissette, 2009, Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt, Am. J. Physiol. -Cell Physiol., 297, 1124, 10.1152/ajpcell.00043.2009 · DOI · Paper page
  189. Amirouche, 2009, Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle, Endocrinology, 150, 286, 10.1210/en.2008-0959 · DOI · Paper page
  190. Eilers, 2020, Local myostatin inhibition improves skeletal muscle glucose uptake in insulin-resistant high-fat diet-fed mice, Am. J. Physiol. Endocrinol. Metab., 319, E163, 10.1152/ajpendo.00185.2019 · DOI
  191. Takahashi, 2014, Myostatin alters glucose transporter-4 (GLUT4) expression in bovine skeletal muscles and myoblasts isolated from double-muscled (DM) and normal-muscled (NM) Japanese shorthorn cattle, Domest. Anim. Endocrinol., 48, 62, 10.1016/j.domaniend.2014.01.007 · DOI
  192. Chen, 2010, Myostatin regulates glucose metabolism via the AMP-activated protein kinase pathway in skeletal muscle cells, Int. J. Biochem. Cell. Biol., 42, 2072, 10.1016/j.biocel.2010.09.017 · DOI
  193. Willis, 2019, Effect of exercise intensity on circulating hepatokine concentrations in healthy men, Appl. Physiol. Nutr. Metab., 44, 1065, 10.1139/apnm-2018-0818 · DOI
  194. Lee, 2001, Regulation of myostatin activity and muscle growth, Proc. Natl. Acad. Sci. USA, 98, 9306, 10.1073/pnas.151270098 · DOI · Paper page
  195. Haines, 2020, OR26-03 Lower Serum Myostatin Levels Are Associated with Higher Insulin Sensitivity in Adults with Overweight/Obesity, J. Endocr. Soc., 4, OR26-03, 10.1210/jendso/bvaa046.497 · DOI
  196. Hjorth, 2016, Myostatin in relation to physical activity and dysglycaemia and its effect on energy metabolism in human skeletal muscle cells, Acta Physiol., 217, 45, 10.1111/apha.12631 · DOI · Paper page
  197. Ryan, 2013, Aerobic exercise + weight loss decreases skeletal muscle myostatin expression and improves insulin sensitivity in older adults, Obesity, 21, 1350, 10.1002/oby.20216 · DOI
  198. Yarasheski, 2002, Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting, J. Nutr. Health Aging, 6, 343
  199. Leger, 2008, Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation, Rejuvenation Res., 11, 163, 10.1089/rej.2007.0588 · DOI · Paper page
  200. Rodriguez, 2017, Crosstalk between adipokines and myokines in fat browning, Acta Physiol., 219, 362, 10.1111/apha.12686 · DOI · Paper page

200 of 294 shown

Cited by

See all 251

Metadata

Authors
Bilski, J., Pierzchalski, P., Szczepanik, M., Bonior, J., & Zoladz, J.
Venue
Cells
Publisher
MDPI AG
Published
2022-01-04
Volume
11
Issue
1
Pages
160
ISSN
2073-4409 (ISSN-L)
OpenAlex
W4206030689
Cited by
251
References
142
FWCI
25.92
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multifactorial Mechanism of Sarcopenia and Sarcopenic Obesity. Role of Physical Exercise, Microbiota and Myokines. https://app.cochat.ai/papers/10.3390/cells11010160
The paper
Bilski, J., Pierzchalski, P., Szczepanik, M., Bonior, J., & Zoladz, J. (2022). Multifactorial Mechanism of Sarcopenia and Sarcopenic Obesity. Role of Physical Exercise, Microbiota and Myokines. Cells. https://doi.org/10.3390/cells11010160

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.